Literature DB >> 117746

Effect of divalent cation concentrations on the antibiotic susceptibilities of nonfermenters other than Pseudomonas aeruginosa.

R J Fass, J Barnishan.   

Abstract

The effects of supplementing Mueller-Hinton broth with calcium and magnesium on the minimal inhibitory concentrations (MICs) of eight aminoglycosides, colistin, tetracycline, and carbenicillin for 11 nonfermenters other than Pseudomonas aeruginosa were studied and compared with the effects for Escherichia coli and P. aeruginosa. MICs were simultaneously performed in unsupplemented Mueller-Hinton broth and Mueller-Hinton broth supplemented to contain 5 mg of calcium and 2.5 mg of magnesium per dl. Changes in MICs were expressed as the increases in the number of log(2) concentrations caused by supplementation. The usual increases in MICs of aminoglycosides caused by supplementation were: zero concentrations for E. coli, one to six concentrations for P. aeruginosa, and one to two concentrations for most other nonfermenters. The largest increases (five to six concentrations) were observed with gentamicin and P. aeruginosa. The usual increases in MICs of colistin were: zero concentrations for E. coli, two concentrations for P. aeruginosa, and one to two concentrations for other nonfermenters. Increases in MICs of tetracycline were: one to five concentrations for all organisms tested. The usual increases in MICs of carbenicillin were: zero concentrations for E. coli and P. aeruginosa and zero to two concentrations for other nonfermenters. These observations indicated that supplementation of Mueller-Hinton broth to contain recommended concentrations of calcium and magnesium had little effect on MICs of aminoglycosides and colistin for E. coli but increased MICs for most nonfermenters, increased MICs of tetracycline for E. coli and all nonfermenters, and had little effect on MICs of carbenicillin for E. coli and P. aeruginosa but increased the MICs for several nonfermenters other than P. aeruginosa.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 117746      PMCID: PMC352878          DOI: 10.1128/AAC.16.4.434

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  The mutual effects of antimicrobial compounds and metallic cations.

Authors:  E D WEINBERG
Journal:  Bacteriol Rev       Date:  1957-03

2.  Site of action of polymyxin on Pseudomonas aeruginosa: antagonism by cations.

Authors:  B A NEWTON
Journal:  J Gen Microbiol       Date:  1954-06

3.  Reversal of the antibacterial activity of polymyxin by divalent cations.

Authors:  B A NEWTON
Journal:  Nature       Date:  1953-07-25       Impact factor: 49.962

4.  The Influence of Certain Substances on the Activity of Streptomycin: III. Differential Effects of Various Electrolytes on the Action of Streptomycin.

Authors:  R Donovick; A P Bayan; P Canales; F Pansy
Journal:  J Bacteriol       Date:  1948-07       Impact factor: 3.490

5.  Effect of calcium and magnesium ions on the susceptibility of Pseudomonas species to tetracycline, gentamicin polymyxin B, and carbenicillin.

Authors:  R F D'amato; C Thornsberry; C N Baker; L A Kirven
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

6.  Effects of divalent cations on binding of aminoglycoside antibiotics to human serum proteins and to bacteria.

Authors:  C H Ramirez-Ronda; R K Holmes; J P Sanford
Journal:  Antimicrob Agents Chemother       Date:  1975-03       Impact factor: 5.191

7.  Locus of divalent cation inhibition of the bactericidal action of polymyxin B.

Authors:  C C Chen; D S Feingold
Journal:  Antimicrob Agents Chemother       Date:  1972-11       Impact factor: 5.191

8.  Activity of aminoglycoside antibiotics aganst Pseudomonas aeruginosa: specificity and site of calcium and magnesium antagonism.

Authors:  V M Zimelis; G G Jackson
Journal:  J Infect Dis       Date:  1973-06       Impact factor: 5.226

9.  Effect of cation content of agar on the activity of gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa.

Authors:  J A Washington; R J Snyder; P C Kohner; C G Wiltse; D M Ilstrup; J T McCall
Journal:  J Infect Dis       Date:  1978-02       Impact factor: 5.226

10.  Antagonistic effect of calcium in serum on the activity of tobramycin against Pseudomonas.

Authors:  S D Davis; A Iannetta
Journal:  Antimicrob Agents Chemother       Date:  1972-06       Impact factor: 5.191

View more
  11 in total

1.  Minimal inhibitory concentrations of 34 antimicrobial agents for control strains Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853.

Authors:  R J Fass; J Barnishan
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

2.  Purification and properties of inducible penicillin beta-lactamase isolated from Pseudomonas maltophilia.

Authors:  Y Saino; F Kobayashi; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191

3.  Quantitative susceptibility test methods in major United States medical centers.

Authors:  P R Murray; J H Jorgensen
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

4.  Effect of calcium, magnesium, and zinc on ticarcillin and tobramycin alone and in combination against Pseudomonas aeruginosa.

Authors:  J J Zuravleff; V L Yu; R B Yee; M K Zaphyr; W Diven; F B Taylor
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

5.  Stably integrated luxCDABE for assessment of Salmonella invasion kinetics.

Authors:  Kelly N Flentie; Min Qi; Seth T Gammon; Yasmin Razia; Felix Lui; Luciano Marpegan; Aashish Manglik; David Piwnica-Worms; Jeffrey S McKinney
Journal:  Mol Imaging       Date:  2008 Sep-Oct       Impact factor: 4.488

6.  A short artificial antimicrobial peptide shows potential to prevent or treat bone infections.

Authors:  N Bormann; A Koliszak; S Kasper; L Schoen; K Hilpert; R Volkmer; J Kikhney; B Wildemann
Journal:  Sci Rep       Date:  2017-05-04       Impact factor: 4.379

7.  In vitro activity of omadacycline and levofloxacin against Escherichia coli, Klebsiella pneumoniae and Staphylococcus saprophyticus in human urine supplemented with calcium and magnesium.

Authors:  Paul Pagano; Andrea Marra; Dean Shinabarger; Chris Pillar
Journal:  J Antimicrob Chemother       Date:  2020-08-01       Impact factor: 5.790

8.  Validation of Selective Agars for Detection and Quantification of Escherichia coli Strains Resistant to Critically Important Antimicrobials.

Authors:  Sam Abraham; David Jordan; Zheng Z Lee; Rebecca Abraham; Mark O'Dea; Ali Harb; Kelly Hunt; Terence Lee
Journal:  Microbiol Spectr       Date:  2021-11-10

9.  Innovative cationic fullerenes as broad-spectrum light-activated antimicrobials.

Authors:  Liyi Huang; Mitsuhiro Terakawa; Timur Zhiyentayev; Ying-Ying Huang; Yohei Sawayama; Ashlee Jahnke; George P Tegos; Tim Wharton; Michael R Hamblin
Journal:  Nanomedicine       Date:  2009-11-12       Impact factor: 5.307

10.  Evaluation of Petrifilm Select E. coli Count Plate medium to discriminate antimicrobial resistant Escherichia coli.

Authors:  Shuyu Wu; Eirini Chouliara; Lars Bogø Jensen; Anders Dalsgaard
Journal:  Acta Vet Scand       Date:  2008-09-25       Impact factor: 1.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.